In The News

San Diego Union-Tribune: San Diego biotech experiments with treatment for Parkinson’s. Now it’s going public

Endpoints News: Aspen and Bambusa target $135M IPOs; AstraZeneca vs. Takeda in gastric cancer ADCs

Delivering Large Genetic Payloads With SonoThera’s Ken Greenberg

The mega-round mindset: How biotechs are thinking bigger and raising smarter

GenomeWeb: SonoThera Targets 2027 for First Clinical Trial of Duchenne Gene Therapy

Technical.ly: Temple University spinout’s ‘Goldilocks molecules’ could change how we take our medicine

Longevity.Technology: SonoThera raises $125m to tackle gene therapy limits

BioXconomy: SonaThera raises $125m to advance ultrasound gene therapy platform

Temple spinout rebrands as Ladder Bio, names new CEO and adds investors

SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery in Treating Duchenne Muscular Dystrophy and Hemophilia A